Cargando…
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
Activation of the Nrf2-Keap1 pathway, the main intracellular defense against environmental stress, has been observed in several human cancers, including hepatocellular carcinoma (HCC). Here, we assessed whether distinct mechanisms of activation may be involved at different stages of hepatocarcinogen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463589/ https://www.ncbi.nlm.nih.gov/pubmed/32824383 http://dx.doi.org/10.3390/cancers12082305 |
_version_ | 1783577166994210816 |
---|---|
author | Orrù, Claudia Perra, Andrea Kowalik, Marta Anna Rizzolio, Sabrina Puliga, Elisabetta Cabras, Lavinia Giordano, Silvia Columbano, Amedeo |
author_facet | Orrù, Claudia Perra, Andrea Kowalik, Marta Anna Rizzolio, Sabrina Puliga, Elisabetta Cabras, Lavinia Giordano, Silvia Columbano, Amedeo |
author_sort | Orrù, Claudia |
collection | PubMed |
description | Activation of the Nrf2-Keap1 pathway, the main intracellular defense against environmental stress, has been observed in several human cancers, including hepatocellular carcinoma (HCC). Here, we assessed whether distinct mechanisms of activation may be involved at different stages of hepatocarcinogenesis. We adopted an experimental model consisting of treatment with diethylnitrosamine (DENA) followed by a choline-devoid methionine-deficient (CMD) diet for 4 months. The CMD diet was then replaced with a basal diet, and the animals were killed at 6, 10 or 13 months after DENA injection. Nrf2 activation occurred at early steps of hepatocarcinogenesis and persisted throughout the tumorigenic process. While Nrf2 mutations were extremely frequent at early steps (90%), their incidence diminished with the progression to malignancy (25%). Conversely, while p62 was almost undetectable in early nodules, its accumulation occurred in HCCs, suggesting that Nrf2 pathway activation at late stages is mainly due to Keap1 sequestration by p62. We demonstrate that, in a model of hepatocarcinogenesis resembling human non-alcoholic fatty liver disease, Nrf2 mutations are the earliest molecular changes responsible for the activation of the Nrf2-Keap1 pathway. The progressive loss of mutations associated with a concomitant p62 accumulation implies that distinct mechanisms are responsible for Nrf2-Keap1 pathway activation at different stages of hepatocarcinogenesis. |
format | Online Article Text |
id | pubmed-7463589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74635892020-09-02 Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis Orrù, Claudia Perra, Andrea Kowalik, Marta Anna Rizzolio, Sabrina Puliga, Elisabetta Cabras, Lavinia Giordano, Silvia Columbano, Amedeo Cancers (Basel) Article Activation of the Nrf2-Keap1 pathway, the main intracellular defense against environmental stress, has been observed in several human cancers, including hepatocellular carcinoma (HCC). Here, we assessed whether distinct mechanisms of activation may be involved at different stages of hepatocarcinogenesis. We adopted an experimental model consisting of treatment with diethylnitrosamine (DENA) followed by a choline-devoid methionine-deficient (CMD) diet for 4 months. The CMD diet was then replaced with a basal diet, and the animals were killed at 6, 10 or 13 months after DENA injection. Nrf2 activation occurred at early steps of hepatocarcinogenesis and persisted throughout the tumorigenic process. While Nrf2 mutations were extremely frequent at early steps (90%), their incidence diminished with the progression to malignancy (25%). Conversely, while p62 was almost undetectable in early nodules, its accumulation occurred in HCCs, suggesting that Nrf2 pathway activation at late stages is mainly due to Keap1 sequestration by p62. We demonstrate that, in a model of hepatocarcinogenesis resembling human non-alcoholic fatty liver disease, Nrf2 mutations are the earliest molecular changes responsible for the activation of the Nrf2-Keap1 pathway. The progressive loss of mutations associated with a concomitant p62 accumulation implies that distinct mechanisms are responsible for Nrf2-Keap1 pathway activation at different stages of hepatocarcinogenesis. MDPI 2020-08-16 /pmc/articles/PMC7463589/ /pubmed/32824383 http://dx.doi.org/10.3390/cancers12082305 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Orrù, Claudia Perra, Andrea Kowalik, Marta Anna Rizzolio, Sabrina Puliga, Elisabetta Cabras, Lavinia Giordano, Silvia Columbano, Amedeo Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis |
title | Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis |
title_full | Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis |
title_fullStr | Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis |
title_full_unstemmed | Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis |
title_short | Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis |
title_sort | distinct mechanisms are responsible for nrf2-keap1 pathway activation at different stages of rat hepatocarcinogenesis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463589/ https://www.ncbi.nlm.nih.gov/pubmed/32824383 http://dx.doi.org/10.3390/cancers12082305 |
work_keys_str_mv | AT orruclaudia distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT perraandrea distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT kowalikmartaanna distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT rizzoliosabrina distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT puligaelisabetta distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT cabraslavinia distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT giordanosilvia distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis AT columbanoamedeo distinctmechanismsareresponsiblefornrf2keap1pathwayactivationatdifferentstagesofrathepatocarcinogenesis |